Document Type
Article
Publication Date
3-4-2023
Publication Title
Epilepsia
Abstract
Selection criteria for clinical trials for medication-resistant epilepsy are used to limit variability and to ensure safety. However, it has become more challenging to recruit subjects for trials. This study investigated the impact of each inclusion and exclusion criterion on medication-resistant epilepsy clinical trial recruitment at a large academic epilepsy center. We retrospectively identified all patients with medication-resistant focal or generalized onset epilepsy who attended an outpatient clinic over a consecutive 3-month period. We assessed each patient's eligibility for trials with commonly required inclusion and exclusion criteria to evaluate the proportion of eligible patients and the most common reasons for exclusion. Among 212 patients with medication-resistant epilepsy, 144 and 28 patients met the criteria for focal or generalized onset epilepsy, respectively. Overall, 9.4% (n = 20) patients were eligible for trials (19 focal onset and one generalized onset). Most patients were excluded from the study due to insufficient seizure frequency (58% of focal onset, 55% of generalized onset). A small proportion of patients with medication-resistant epilepsy were eligible for trials based on common selection criteria. These eligible patients may not be representative of the general population of patients with medication-resistant epilepsy. Insufficient seizure frequency was the most common reason for exclusion.
First Page
e56
Last Page
e60
PubMed ID
36869635
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
Kerr, Wesley T.; Chen, Hai; Figuera Losada, Mariana; Cheng, Christopher; Liu, Tiffany; and French, Jaqueline, "Reasons for ineligibility for clinical trials of patients with medication-resistant epilepsy" (2023). School of Medicine Faculty Publications. 876.
https://digitalscholar.lsuhsc.edu/som_facpubs/876
10.1111/epi.17568
File Format
File Size
440 KB
Included in
Chemical Actions and Uses Commons, Nervous System Diseases Commons, Neurology Commons, Pathological Conditions, Signs and Symptoms Commons